about
Cardiolipin signaling mechanisms: collapse of asymmetry and oxidationCharacterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiencySuccessful management of Barth syndrome: a systematic review highlighting the importance of a flexible and multidisciplinary approachThe role of peroxidation of mitochondrial membrane phospholipids in pancreatic β -cell failureCardiolipin and its different properties in mitophagy and apoptosisCell cycle arrest and cell survival induce reverse trends of cardiolipin remodelingRedox regulation of mitochondrial functionDisorders of phospholipid metabolism: an emerging class of mitochondrial disease due to defects in nuclear genesMitochondrial Metabolism in Aging HeartDietary macronutrients modulate the fatty acyl composition of rat liver mitochondrial cardiolipinsChemotherapy Drug Induced Discoordination of Mitochondrial Life Cycle Detected by Cardiolipin FluctuationThe complexity of cardiolipin in health and diseaseAssessing phospholipase A2 activity toward cardiolipin by mass spectrometryGroup VIA phospholipase A2 mitigates palmitate-induced β-cell mitochondrial injury and apoptosisThe role of calcium-independent phospholipase A2 in cardiolipin remodeling in the spontaneously hypertensive heart failure rat heartUpdate on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acidsA mathematical model for the determination of steady-state cardiolipin remodeling mechanisms using lipidomic data.Dysregulation of cardiolipin biosynthesis in pediatric heart failure.Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity.Improved mitochondrial function with diet-induced increase in either docosahexaenoic acid or arachidonic acid in membrane phospholipids.Dietary supplementation with docosahexaenoic acid, but not eicosapentaenoic acid, dramatically alters cardiac mitochondrial phospholipid fatty acid composition and prevents permeability transition.The functions of cardiolipin in cellular metabolism-potential modifiers of the Barth syndrome phenotypeMitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus.Improved functional recovery to I/R injury in hearts from lipocalin-2 deficiency mice: restoration of mitochondrial function and phospholipids remodelingTurnover of nonessential fatty acids in cardiolipin from the rat heart.Lysocardiolipin acyltransferase 1 (ALCAT1) controls mitochondrial DNA fidelity and biogenesis through modulation of MFN2 expression.Blockade of electron transport at the onset of reperfusion decreases cardiac injury in aged hearts by protecting the inner mitochondrial membrane.Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.Non-targeted metabolomics of Brg1/Brm double-mutant cardiomyocytes reveals a novel role for SWI/SNF complexes in metabolic homeostasis.Myocardial regulation of lipidomic flux by cardiolipin synthase: setting the beat for bioenergetic efficiency.Group VIB Phospholipase A(2) promotes proliferation of INS-1 insulinoma cells and attenuates lipid peroxidation and apoptosis induced by inflammatory cytokines and oxidant agentsThe mitochondrial Ca2+ uniporter: regulation by auxiliary subunits and signal transduction pathways.Mitochondria and heart failure: new insights into an energetic problem.The NO/ONOO-cycle as the central cause of heart failure.Dietary omega-3 fatty acids alter cardiac mitochondrial phospholipid composition and delay Ca2+-induced permeability transition.Formation and regulation of mitochondrial membranes.Mitochondrially targeted nitro-linoleate: a new tool for the study of cardioprotection.Expert consensus document: Mitochondrial function as a therapeutic target in heart failureDiversity and function of membrane glycerophospholipids generated by the remodeling pathway in mammalian cells.Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases.
P2860
Q23923191-12482E2D-6351-40D5-BBA6-02D3ABFD0B58Q24604918-8BDB0F2A-FDA5-4F92-97BE-1F7041EE780DQ26801275-A014ABFF-A924-49D8-AEB6-8E9EF1173A54Q26995759-B00D0088-B8D5-4F13-BD8E-CB54612F16B4Q27024440-A6CACC23-CB2B-48E9-9C1C-1CD03208E560Q28383069-6723A5B4-A814-4573-A8AB-3DB3DF8BB257Q28383361-5197D892-958E-46EE-8275-30675EC798C9Q28387241-AFF56B6C-6754-4F5A-BD18-941C28CB19AEQ28388306-BF98A0EB-0852-4B9A-897A-029D35479859Q28388441-93557EC7-4C25-4F24-807C-5847305F49B4Q28389330-461E9781-D4D5-4944-94A3-ED0316ED826FQ28395624-E12FD17D-3F06-4A3A-AE36-00A1A0C9D976Q28396086-4C9E9B8A-EF5C-4F49-A17F-C6C429E88AD9Q33619491-FD847BC9-FF57-48E4-865C-89C5F3C37FB0Q33634137-BC8AF3E7-D3FC-4D7D-B1D6-5F4C248A7586Q33792723-CB08EE65-815D-441A-9836-5FECB04AE240Q33939499-E6B8FFF7-20AA-4366-B5AE-3E9B1B34BCB6Q33969031-AF782C1A-E2CF-4549-8219-3DD0B13AEFDEQ34072371-707F06D3-4ED3-4E8D-BB08-C57AFF421F34Q34222543-A4C2F2D1-2E9F-43F7-B1A9-66B8C87DCAEFQ34767042-A0038DED-1E54-44D4-96DB-3B0D2B065411Q35128445-2274D72F-3D55-4F46-9F0B-3C3D188A3D24Q35550591-4773EF4D-0997-4E08-A67E-0A49CB5E78B5Q35759703-7A129D93-6625-4E09-B3E4-9C454A57BD83Q35768573-6ADDB8E0-5558-4813-998F-53F4E5C1768AQ35935796-3BDE79E7-B1F8-43DA-9A3B-BBEE39287D63Q35944872-F16C257F-48D5-44AB-AD34-3428E6C008F4Q35974413-F914D8D7-6472-46D0-99C4-ED9748EFF38BQ36071801-4E8DD47B-30B9-4907-BC03-8D96E1777264Q36127040-861BB379-0654-4821-BA5D-738B71930F2AQ36415597-18B2059D-16CB-435D-8C3D-785A3448E454Q37139385-F6D9B5F0-FAA3-4604-B942-5C9B6F9167DBQ37206330-7B5BB46F-5782-456E-A1B5-978D6F8B7866Q37375441-4A768614-FE89-4972-AA4D-9A326DBE1285Q37441247-4E5455D4-D0F6-4D57-88F7-A04C38149122Q37571518-0C08CD7A-3EE7-4198-BA0A-B358872F4A80Q37686281-3E72E42E-DD35-4256-BFA9-6801C0C7E2DDQ37699474-D2E48803-F973-4BF7-B1D8-8D55198DCB76Q37716341-DAE14704-5595-4546-8EFF-B8E486DAA35EQ38095919-55057836-2937-4F8F-99BF-3CFAB484C1E1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cardiolipin remodeling in the heart.
@en
Cardiolipin remodeling in the heart.
@nl
type
label
Cardiolipin remodeling in the heart.
@en
Cardiolipin remodeling in the heart.
@nl
prefLabel
Cardiolipin remodeling in the heart.
@en
Cardiolipin remodeling in the heart.
@nl
P1476
Cardiolipin remodeling in the heart.
@en
P2093
Edward J Lesnefsky
Genevieve C Sparagna
P304
P356
10.1097/FJC.0B013E31819B5461
P407
P577
2009-04-01T00:00:00Z